Sirolimus improves early microcirculation, but impairs regeneration after pancreatic ischemia-reperfusion injury

American Journal of Transplantation

Volumn 7, Issue 1, 2007, Pages 48-56

  Serr, F ^a   Lauer, H ^a   Armann, B ^a   Ludwig, S ^a   Thiery, J ^a   Fiedler, M ^a   Ceglarek, U ^a   Tannapfel, A ^b   Uhlmann, D ^a   Hauss, J ^a   Witzigmann, H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Intravital microscopy; Ischemia reperfusion injury; Microcirculation; Pancreas; Recovery; Sirolimus

Indexed keywords

RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EARLY DIAGNOSIS; FLUORESCENCE MICROSCOPY; GRAFT REJECTION; HISTOPATHOLOGY; LEUKOCYTE MIGRATION INHIBITION; MALE; MICROCIRCULATION; NONHUMAN; PANCREAS INJURY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SHAM FEEDING; SPECIES COMPARISON; THERAPY DELAY; THERAPY EFFECT; THROMBOCYTE AGGREGATION INHIBITION; TISSUE REGENERATION; TISSUE SECTION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; CELL ADHESION; CELL PROLIFERATION; HEAT; LEUKOCYTES; MALE; MICROCIRCULATION; PANCREAS; PANCREAS TRANSPLANTATION; RATS; RATS, INBRED LEW; REGENERATION; REPERFUSION INJURY; SIROLIMUS; SPLANCHNIC CIRCULATION; TIME FACTORS;

EID: 33845674654     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01589.x     Document Type: Article

References (42)

1. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg 2002; 26: 194-211.
2. Grewal HP, Garland L, Novak K, Gaber L, Tolley EA, Gaber AO. Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients. Transplantation 1993; 56: 609-612.
3. Benz S, Schnabel R, Morgenroth K, Weber H, Pfeffer F, Hopt UT. Ischemia/reperfusion injury of the pancreas: a new animal model. J Surg Res 1998; 75: 109-115.
4. Benz S, Pfeffer F, Adam U, Schareck W, Hopt UT. Impairment of pancreatic microcirculation in the early reperfusion period during simultaneous pancreas-kidney transplantation. Transpl Int 1998; 11(Suppl 1): S433-S435.
5. Mayer H, Schmidt J, Thies J et al. Characterization and reduction of ischemia/reperfusion injury after experimental pancreas transplantation. J Gastrointest Surg 1999; 3: 162-166.
6. Witzigmann H, Ludwig S, Armann B et al. Endothelin(A) receptor blockade reduces ischemia/reperfusion injury in pig pancreas transplantation. Ann Surg 2003; 238: 264-274.
7. Sehgal SN. Rapamune (sirolimus, rapamycin): An overview and mechanism of action. Ther Drug Monit 1995; 17: 660-665.
8. Puglisi RN, Strande L, Santos M, Schulte G, Hewitt CW, Whalen TV. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury. J Surg Res 1996; 65: 115-118.
9. Matsuda T, Yamaguchi Y, Matsumura F et al. Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats. J Trauma 1998; 44: 475-484.
10. Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003; 76: 1594-1599.
11. Lieberthal W, Fuhro R, Andry CC et al. Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001; 281: F693-F706.
12. Lieberthal W, Fuhro R, Andry C, Patel V, Levine JS. Rapamycin delays but does not prevent recovery from acute renal failure: Role of acquired tubular resistance. Transplantation 2006; 82: 17-22.
13. McTaggart RA, Gottlieb D, Brooks J et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 416-423.
14. Stallone G, Di Paolo S, Schena A et al. Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. J Am Soc Nephrol 2004; 15: 228-233.
15. Guba M, von Breitenbuch P, Steinbauer M et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128-135.
16. Menger MD, Vollmar B. Role of microcirculation in transplantation. Microcirculation 2000; 7: 291-306.
17. Hoffmann TF, Leiderer R, Waldner H, Arbogast S, Messmer K. Ischemia reperfusion of the pancreas: A new in vivo model for acute pancreatitis in rats. Res Exp Med (Berl) 1995; 195: 125-144.
18. Massberg S, Enders G, Leiderer R et al. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of P-selectin. Blood 1998; 92: 507-515.
19. Schmid-Schoenbein GW, Zweifach BW, Kovalcheck S. The application of stereological principles to morphometry of the microcirculation in different tissues. Microvasc Res 1977; 14: 303-317.
20. Witzigmann H, Spiegel HU, Hauss J. Untersuchungen zur Konservierung von Leber, Niere und Pankreas mit der HTK- und UW-Lösung am Hundemodell. Pabst Science Publishers 2000: 42-45. ISBN 3-934252-92-3.
21. Knight RJ, Kahan BD. Impact of sirolimus on early graft function after deceased-donor kidney transplantation. Transplantation 2005; 79: 991-992.
22. DiJoseph JF, Fluhler E, Armstrong J, Sharr M, Sehgal SN. Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat. Transplantation 1996; 62: 1109-1112.
23. DiJoseph JF, Sharma RN, Chang JY. The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 1992; 53: 507-513.
24. Farkas S, Hornung M, Sattler C et al. Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis. Int J Colorectal Dis 2005; 21: 747-753.
25. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001; 8: 187-194.
26. Khandoga A, Biberthaler P, Enders G et al. Platelet adhesion mediated by fibrinogen-intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation 2002; 74: 681-688.
27. Keck T, Werner J, Schneider L, Gebhard MM, Klar E. Characterization of ischemia/reperfusion injury after pancreas transplantation and reduction by application of monoclonal antibodies against ICAM-1 in the rat. Surgery 2003; 134: 63-71.
28. Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion. Transplantation 1994; 57: 933-941.
29. Viklicky O, Zou H, Muller V, Lacha J, Szabo A, Heemann U. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts. Transplantation 2000; 69: 497-502.
30. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 1099-1105.
31. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler R. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.
32. Li Y, Chopp M, Jiang N, Zhang ZG, Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 1995; 26: 1252-1257.
33. Schumer M, Colombel MC, Sawczuk IS et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992; 140: 831-838.
34. Fujimoto K, Hosotani R, Wada M et al. Ischemia-reperfusion injury on the pancreas in rats: Identification of acinar cell apoptosis. J Surg Res 1997; 71: 127-136.
35. Drognitz O, Obermaier R, Liu X et al. Effects of organ preservation, ischemia time and caspase inhibition on apoptosis and microcirculation in rat pancreas transplantation. Am J Transplant 2004; 4: 1042-1050.
36. Woltman AM, de Fijter JW, Kamerling SW et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 2001; 98: 174-180.
37. Migita K, Eguchi K, Ichinose Y et al. Effects of rapamycin on apoptosis of rheumatoid synovial cells. Clin Exp Immunol 1997; 108: 199-203.
38. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the proapoptotic molecule BAD. Proc Natl Acad Sci U S A 2001; 98: 9666-70.
39. Lutz J, Zou H, Liu S, Antus B, Heemann U. Apoptosis and treatment of chronic allograft nephropathy with everolimus. Transplantation 2003; 76: 508-515.
40. Schachner T, Oberhuber A, Zou Y et al. Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts. Eur J Cardiothorac Surg 2005; 27: 302-306.
41. Francavilla A, Carr BI, Starzl TE, Azzarone A, Carrieri G, Zeng QH. Effects of rapamycin on cultured hepatocyte proliferation and gene expression. Hepatology 1992; 15: 871-877.
42. Boylan JM, Anand P, Gruppuso PA. Ribosomal protein S6 phosphorylation and function during late gestation liver development in the rat. J Biol Chem 2001; 276: 44457-44463.